跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
D-660
首页
药物
D-660
D-660
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Alcohol dehydrogenase 2 (ADH2) promoter variants by promoter engineering
申请人: ORTA DOGU TEKNIK UNIV
优先权: 2018
CN
US
2 件公开
Immune-stimulating photoactive hybrid nanoparticles
申请人: DHAR SHANTA
优先权: 2012
US
2 件公开
Nitric oxide nano prodrug as well as preparation method and application thereof
申请人: GUANGZHOU FIRST PEOPLES HOSPITAL GUANGZHOU DIGESTIVE DISEASE CENTER FIRST PEOPLES HOSPITAL AFFILIATE
优先权: 2022
CN
Preparation and application of water-stable organic free radical supramolecular crystal
申请人: UNIV WUHAN SCIENCE & TECH
优先权: 2023
CN
Triphenylamine amphiphilic fluorescent probe as well as preparation method and application thereof
申请人: UNIV ANHUI XINHUA
优先权: 2026
CN
药物
反馈